Suppr超能文献

硫利达嗪对去甲肾上腺素或钾诱导的人输精管机械反应的影响。

Effects of thioridazine on mechanical responses of human vas deferens induced by noradrenaline or potassium.

作者信息

Amobi N I, Smith I C

机构信息

Biomedical Sciences Division, King's College London, UK.

出版信息

J Reprod Fertil. 1992 May;95(1):1-10. doi: 10.1530/jrf.0.0950001.

Abstract

Thioridazine (0.1-10 mumol l-1) inhibited shortening of specimens of human vasa deferentia induced by noradrenaline (100 mumol l-1) or high extracellular potassium (136 mmol l-1). Thioridazine did not inhibit the lengthening response. In Ca(2+)-free media with EGTA (0.5 mmol l-1) similar results were obtained with responses to noradrenaline, but exposure to potassium elicited small contractions that were potentiated by thioridazine. Both shortening and lengthening responses to noradrenaline were antagonized by the alpha-adrenoceptor blockers prazosin (1-10 mumol l-1) and phentolamine (1-10 mumol l-1) and by the Ca2+ antagonists verapamil (10 mumol l-1) and diltiazem (10 mumol l-1). Responses to potassium were virtually abolished by the Ca2+ antagonists. These results show that thioridazine specifically inhibits longitudinal muscle of the human vas deferens and that its action cannot be entirely accounted for by a blockade of voltage-gated Ca2+ channels.

摘要

硫利达嗪(0.1 - 10 μmol l⁻¹)抑制去甲肾上腺素(100 μmol l⁻¹)或高细胞外钾(136 mmol l⁻¹)诱导的人输精管标本缩短。硫利达嗪不抑制延长反应。在含有乙二醇双(2-氨基乙基醚)四乙酸(EGTA,0.5 mmol l⁻¹)的无钙培养基中,对去甲肾上腺素的反应得到类似结果,但暴露于钾会引发小的收缩,硫利达嗪可增强这种收缩。对去甲肾上腺素的缩短和延长反应均被α-肾上腺素能受体阻滞剂哌唑嗪(1 - 10 μmol l⁻¹)和酚妥拉明(1 - 10 μmol l⁻¹)以及钙拮抗剂维拉帕米(10 μmol l⁻¹)和地尔硫䓬(10 μmol l⁻¹)拮抗。对钾的反应几乎被钙拮抗剂消除。这些结果表明,硫利达嗪特异性抑制人输精管的纵行肌,其作用不能完全由电压门控钙通道的阻断来解释。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验